Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.33 |
| ▸ | HTR1A | P08908 | 3/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1660045 | 0.95 | HDAC4 (0.36) | HTR2CTAAR1ADRA1AHTR1AADRA1D | |
| SCHEMBL1659045 | 0.79 | GRM5 (0.30) | — | |
| SCHEMBL1661148 | 0.79 | MGLL (0.39) | HTR2CTAAR1NOTUMALOX5KCNH2 | |
| SCHEMBL1660420 | 0.75 | SOD1 (0.39) | — | |
| SCHEMBL1661901 | 0.74 | ABCG2 (0.43) | — | |
| SCHEMBL2865183 | 0.74 | KMO (0.46) | HTR2CKCNH2 | |
| SCHEMBL2638262 | 0.74 | KMO (0.43) | HTR2CALOX5KCNH2 | |
| SCHEMBL1660445 | 0.66 | ACHE (0.36) | ADRA1AHTR1ADRD2 | |
| SCHEMBL1660051 | 0.64 | ACHE (0.36) | — | |
| SCHEMBL16892469 | 0.63 | HTR2C (0.49) | HTR2CADRA1AHTR1AADRA1DADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2011526625-A | — | — | 2011-10-13 | — | — | JP | claimed |
| EP-2307394-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Amorepacific Corporation (KR) | 2011-04-13 | — | — | EP | claimed |
| WO-2010002209-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2010-01-07 | — | — | WO | claimed |